Regulation of cell motile activity through the different induction of LPA receptors by estrogens in liver epithelial WB-F344 cells

Biochemical and Biophysical Research Communications

Volumn 428, Issue 1, 2012, Pages 105-109

  Tanabe, Eriko ^a   Shibata, Ayano ^a   Inoue, Serina ^a   Kitayoshi, Misaho ^a   Fukushima, Nobuyuki ^a   Tsujiuchi, Toshifumi ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Cell motility; Estrogen; LPA; LPA receptor

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE SILENCING; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL MOVEMENT; EPITHELIAL CELLS; ESTROGENS; LIVER; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID;

RATTUS;

EID: 84868363876     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.10.015     Document Type: Article

References (27)

1. Lin M.-E., Herr D.R., Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010, 91:130-138.
2. Ishii I., Fukushima N., Ye X., Chun J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 2004, 73:321-354.
3. Fukushima N., Ishii I., Contos J.A., Weiner J.A., Chun J. Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 2001, 41:507-534.
4. Noguchi K., Herr D., Mutoh T., Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr. Opin. Pharmacol. 2009, 9:15-23.
5. Ishii S., Noguchi K., Yanagida K. Non-Edg family lysophosphatidic acid (LPA) receptors. Prostaglandins Other Lipid Mediat. 2009, 89:57-65.
6. Contos J.J.A., Ishii I., Chun J J. Lysophosphatidic acid receptors. Mol. Pharmacol. 2000, 58:1188-1196.
7. Yu S., Murph M.M., Lu Y., Liu S., Hall H.S., Liu J., Stephens C., Fang X., Mills G.B. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J. Natl. Cancer Inst. 2008, 100:1630-1642.
8. Okabe K., Hayashi M., Kato K., Okumura M., Fukui R., Honoki K., Fukushima N., Tsujiuchi T. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol. Carcinog. 2012, 10.1002/mc.21851.
9. Hayashi M., Okabe K., Kato, Okumura M., Fukui R., Honoki K., Fukushima N., Tsujiuchi T. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. 2012, 316:91-96.
10. Hayashi M., Okabe K., Yamawaki Y., Teranishi M., Honoki K., Mori T., Fukushima N., Tsujiuchi T. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem. Biophys. Res. Commun. 2011, 405:450-454.
11. Boon W.C., Chow J.D., Simpson E.R. The multiple roles of estrogens and the enzyme aromatase. Prog. Brain Res. 2010, 181:209-232.
12. Giretti M.S., Simoncini T. Rapid regulatory actions of sex steroids on cell movement through the actin cytoskeleton. Steroids 2008, 73:895-900.
13. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 2000, 27:67-73.
14. Coelingh Bennink H.J. Are all estrogens the same?. Maturitas 2004, 47:269-275.
15. Maier W.E., Herman J.R. Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals. Regul. Toxicol. Pharmacol. 2001, 34:53-61.
16. Okabe K., Kato K., Teranishi M., Okumura M., Fukui R., Mori T., Fukushima N., Tsujiuchi T. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett. 2011, 309:236-242.
17. Kato K., Yoshikawa K., Tanabe E., Kitayoshi M., Fukui R., Fukushima N., Tsujiuchi T. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells. Tumor Biol. 2012, 10.1007/s13277-012-0433-0.
18. Shano S., Hatanaka K., Ninose S., Moriyama R., Tsujiuchi T., Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim. Biophys. Acta 2008, 1783:748-759.
19. Feigelson H.S., Henderson B.E. Estrogens and breast cancer. Carcinogenesis 1996, 17:2279-2284.
20. Li J.J., Li S.A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc. 1987, 46:1856-1863.
21. Yager J.D., liehr J.G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 1996, 36:203-232.
22. Newbold R.R. Lesson learned from perinatal exposure to diethylstilbestrol. Toxicol. Appl. Pharmacol. 2004, 199:142-150.
23. Di Maio M., Daniele B., Pignata S., Gallo C., De Maio E., Morabito A., Piccirillo M.C., Perrone F. Is human hepatocellular carcinoma a hormone-responsive tumor?. World J. Gastroenterol. 2008, 14:1682-1689.
24. Kalra M., Mayes J., Assefa S., Kaul A.K., Kaul R. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J. Gastroenterol. 2008, 14:5945-5961.
25. De Maria N., Manno M., Villa E. Sex hormones and liver cancer. Mol. Cell. Endocrinol. 2002, 193:59-63.
26. Obo Y., Yamada T., Furukawa M., Hotta M., Honoki K., Fukushima N., Tsujiuchi T. Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors. Mutat. Res. 2009, 660:47-50.
27. Yamada T., Furukawa M., Hotta M., Yamasaki A., Honoki K., Fukushima N., Tsujiuchi T. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats. Biochem. Biophys. Res. Commun. 2009, 378:424-427.